| Citation: |
YI Ping, ZHANG Zhiming, LIN Jiayao, REN Yuan, OUYANG Gaoxiong, LIU Chunhui, FENG Zhongxu, LV Qingjie, LIU Jianyong. Immunological Competence of Dendritic Cell Vaccine Loaded with CD133+ Hepatocellular Carcinoma Cell RNA[J]. Cancer Research on Prevention and Treatment, 2017, 44(3): 184-188. DOI: 10.3971/j.issn.1000-8578.2017.03.006
|
To investigate the immunological competence of dendritic cell loaded with CD133+ hepatocellular carcinoma cell RNA (CD133+ HCC RNA-DC) vaccine.
HCC cells were separated from hepatocellular carcinoma tissues through Enzyme Digestion, and then CD133+ HCC cells were sorted by flow cytometry. CD133+ HCC RNA-DC vaccine was obtained. Flow cytometry was used to detect the phenotype of DC, and ELISA was applied to determine the level of DC's secretion of IL-12. Mixed lymphocyte reaction was applied to test the ability of DC to stimulate the proliferation of autologous T lymphocytes in vitro.
The expression levels of HLA-ABC, HLA-DR, CD86, CD80 and CD83 in CD133+ HCC RNA-DC group were (96.52±2.02)%, (92.17±3.04)%, (94.25±3.28)%, (55.14±1.67)% and (40.53±2.31)%, respectively. Phenotypes expression levels were not significantly different among CD133+ HCC RNA-DC, HCC-DC and mature DC. The secretion of IL-12 in CD133+ HCC RNA-DC group, HCC-DC group, mature DC group and immature DC group were (421.50±3.12), (418.20±1.10), (324.20±2.19) and (102.47±4.60) pg/ml, respectively; the difference of the former two had no statistical significance (P=0.14), and the amounts of the former two were higher than that of the latter two (P < 0.05). The proliferation of autologous T lymphocytes stimulated by CD133+ HCC RNA-DC and HCC-DC were stronger than those by mature DC and no DC (P < 0.05).
The dendritic cell vaccine loaded with CD133+ hepatocellular carcinoma cell RNA (CD133+ HCC RNA-DC) has mature phenotype and can effectively stimulate the proliferation of autologous T lymphocytes in vitro.
| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. Ca Cancer J Clin, 2016, 66(2): 115-32. doi: 10.3322/caac.21338
|
| [2] |
Dillman RO, Mcclay EF, Barth NM, et al. Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-term Survival by Extent of Disease at the Time of Treatment[J]. Cancer Biother Radiopharm, 2015, 30(5): 187-94. doi: 10.1089/cbr.2015.1843
|
| [3] |
Anguille S, Smits EL, Lion E, et al. Clinical use of dendritic cells for cancer therapy[J]. Lancet Oncol, 2014, 15(7): e257-67. doi: 10.1016/S1470-2045(13)70585-0
|
| [4] |
肖宗宇, 陈晓娟, 杨艺, 等.肿瘤干细胞样细胞RNA致敏树突状细胞治疗大鼠9L脑肿瘤[J].北京大学学报 (医学版), 2015, 47(4): 661-6. http://www.cnki.com.cn/Article/CJFDTOTAL-BYDB201504025.htm
Xiao ZY, Chen XJ, Yang Y, et al. Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors[J]. Beijing Da Xue Xue Bao (Yi Xue Ban), 2015, 47(4): 661-6. http://www.cnki.com.cn/Article/CJFDTOTAL-BYDB201504025.htm
|
| [5] |
Chan AW, Tong JH, Chan SL, et al. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma[J]. Histopathology, 2014, 64(7): 935-50. doi: 10.1111/his.2014.64.issue-7
|
| [6] |
林家耀, 张志明, 刘剑勇, 等.肝细胞性肝癌组织CD133+细胞肿瘤干细胞特性的研究[J].中华肿瘤防治杂志, 2016, 23(4): 223-7, 232. http://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201604006.htm
Lin JY, Zhang ZM, Liu JY, et al. Identification and characterization of cancer stem cells from CD133+ cells separated from hepatocellular carcinoma tissue[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2016, 23(4): 223-7, 232. http://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201604006.htm
|
| [7] |
Ma Y, Shurin GV, Peiyuan Z, et al. Dendritic Cells in the Cancer Microenvironment[J]. J Cancer, 2013, 4(1): 36-44. doi: 10.7150/jca.5046
|
| [8] |
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance[J]. Nat Rev Cancer, 2005, 5(4): 263-74. doi: 10.1038/nrc1586
|
| [9] |
Tada F, Abe M, Hirooka M, et al. PhaseⅠ/Ⅱ study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma[J]. Int J Oncol, 2012, 41(5): 1601-9. https://www.researchgate.net/publication/230841343_Phase_III_study_of_immunotherapy_using_tumor_antigen-pulsed_dendritic_cells_in_patients_with_hepatocellular_carcinoma
|
| [10] |
Sun TY, Yan W, Yang CM, et al. Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer[J]. Genet Mol Res, 2015, 14(4): 16222-32. doi: 10.4238/2015.December.8.12
|
| [11] |
冯钟煦, 刘剑勇, 赵荫农, 等. H22细胞全细胞抗原负载的树突状细胞激活肿瘤浸润性淋巴细胞抗小鼠肝癌的实验[J].肿瘤防治研究, 2012, 39(10): 1179-82. doi: 10.3971/j.issn.1000-8578.2012.10.005
Feng ZX, Liu JY, Zhao YN, et al. Anti-mouse Hepatoma Effect of Tumor-infiltrating Lymphocyte Stimulated by DCs Pulsed with H22 Full-cell Antigen[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(10): 1179-82. doi: 10.3971/j.issn.1000-8578.2012.10.005
|
| [12] |
谭德敏, 向阳, 谭千林.狼疮性肾炎患者外周血树突状细胞功能的研究[J].中国免疫学杂志, 2016, 32(4): 570-2. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201604029.htm
Tan DM, Xiang Y, Tan QL. Study on immune function of blood dendritic cells in patients with lupus nephritis[J]. Zhongguo Mian Yi Xue Za Zhi, 2016, 32(4): 570-2. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201604029.htm
|
| [13] |
江龙委, 蔡凯, 黄伟谦, 等. rhG-CSF与rhGM-CSF动员人外周血单核细胞后DC疫苗数量及功能变化的比较[J].肿瘤防治研究, 2015, 42(11): 1095-9. doi: 10.3971/j.issn.1000-8578.2015.11.008
Jiang LW, Cai K, Huang WQ, et al. Comparison of rhG-CSF and rhGM-CSF Mobilization on Quantity and Function Change of Dendritic Cell-based Tumor Vaccine via Human Peripheral Blood Monocytes[J]. Zhong Liu Fang Zhi Yan Jiu, 2015, 42(11): 1095-9. doi: 10.3971/j.issn.1000-8578.2015.11.008
|
| [14] |
Kyte JA, Mu L, Aamdal S, et al. PhaseⅠ/Ⅱ trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA[J]. Cancer gene ther, 2006, 13(10): 905-18. doi: 10.1038/sj.cgt.7700961
|
| [15] |
Gao D, Li C, Xie X, et al. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients[J]. PLoS One, 2014, 9(4): e93886. doi: 10.1371/journal.pone.0093886
|
| [16] |
Xi HB, Wang GX, Fu B, et al. Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer[J]. Biol Pharm Bull, 2015, 38(6): 827-35. doi: 10.1248/bpb.b14-00518
|
| [17] |
Sun JC, Pan K, Chen MS, et al. Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells[J]. Cancer Biol Ther, 2010, 10(4): 368-75. doi: 10.4161/cbt.10.4.12440
|
| [1] | HOU Chan, WEI Hailiang, LI Jingtao, YAN Shuguang, ZHOU Jun. Advances in Non-coding RNA Regulating Kupffer Cell Polarization in Intervention of Malignant Transformation of Precancerous Lesions of Liver[J]. Cancer Research on Prevention and Treatment, 2019, 46(9): 851-855. DOI: 10.3971/j.issn.1000-8578.2019.19.0171 |
| [2] | JIANG Longwei, CAI Kai, HUANG Weiqian, ZHANG Yan, ZHANG Chuang, GAO Yanrong, AI Yueqin, JIA Shaochang, DING Rongrong. Comparison of rhG-CSF and rhGM-CSF Mobilization on Quantity and Function Change of Dendritic Cell-based Tumor Vaccine via Human Peripheral Blood Monocytes[J]. Cancer Research on Prevention and Treatment, 2015, 42(11): 1095-1099. DOI: 10.3971/j.issn.1000-8578.2015.11.008 |
| [3] | YANG Kang, LI Youyuan, YU Junfeng, WEI Shaozhong. Updates of Immunotherapy on Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 929-932. DOI: 10.3971/j.issn.1000-8578.2015.09.015 |
| [4] | SONG Yimin, WANG Yingzi, LV Xinquan, XUE Jinhui, LI Huixiang. Relationship of ALDH1+/CD133+ Stem Cell-like Cells with Angiogenesis in Breast Invasive Ductal Carcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2015, 42(07): 706-711. DOI: 10.3971/j.issn.1000-8578.2015.07.014 |
| [5] | LIANG Hongxiang, ZHONG Hong, LUO Yong, HUANG Yan, DING Zhaoheng, DING Gang. Expression and Signifi cance of Cancer Stem Cell Markers CD133, CD44, SOX2, OCT4 and ALDH1 in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1138-1142. DOI: 10.3971/j.issn.1000-8578.2013.12.007 |
| [6] | CHENG Yan, YAO Li, CUI Jinquan. Effects of Small Interfering RNA Specific to Stable Transfection Gene of PGRMC1 on Proliferation of Ovarian Carcinoma in vitro[J]. Cancer Research on Prevention and Treatment, 2013, 40(07): 652-655. DOI: 10.3971/j.issn.1000-8578.2013.07.006 |
| [7] | YU Li, ZOU Tian, YANG Gui-ling, DAI Yu-cheng, WU Qiong, YANG Bi-yun, LI Jie. Anti-Chronic Myelocytic Leukemia Induced by Dentritic Cells Transfected with RNA-lipofectamin[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 47-51. DOI: 10.3971/j.issn.1000-8578.2010.01.013 |
| [8] | GONG Hui-lin, XU Chang-fu, MO Li-ping, ZHANG Jian. Effect of PA on Antitumor Activity of DC Vaccine in vitro[J]. Cancer Research on Prevention and Treatment, 2009, 36(06): 479-482. DOI: 10.3971/j.issn.1000-8578.2009.06.008 |
| [9] | PAN Li-feng, LI Qiao-xia, SHAN Bao-en, WANG Jun-xia. The Inhibitory Effect of VEGF Antisense RNA for Esophageal Cancer Cells in Vivo[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 457-459. DOI: 10.3971/j.issn.1000-8578.1601 |
| [10] | LIU Li, SUN Bing-zhong, LIANG Ying-min, et al, . The Effect of Telomerase Antisense RNA on Telomerase Activity and Cell Proliferation of HL-60[J]. Cancer Research on Prevention and Treatment, 2001, 28(01): 4-6. DOI: 10.3971/j.issn.1000-8578.37 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: